companies / carislabusa-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 168,000,000168.0M | ○ |
|---|---|---|
| founded | 2008 | |
| hq | Irving TX | |
| industry | unknown | |
| stage | series-b+ |
Caris Life Sciences runs a molecular-diagnostics lab that profiles tumors across DNA, RNA, and protein for precision-oncology decisions. It serves oncologists and pharma partners stratifying patients by molecular drivers. Its Molecular Intelligence database links treatment outcomes to comprehensive molecular profiles in a longitudinal corpus rivals can't replicate.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-04-01 | seed | 168,000,000168.0M | null | ○ |
| fact | status | src |
|---|---|---|
| Seed, $168.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |